Related Experiment Video
Updated: Aug 24, 2026

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
Published on: March 30, 2018
Allogeneic stem cell-derived "repair unit" therapy and the barriers to clinical deployment
Terry B Strom1, Loren J Field, Manfred Ruediger
1Department of Medicine, Harvard Medical School, and Division of Immunology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. tstrom@caregroup.harvard.edu
Abstract:
The development of cellular therapies has been seriously hampered by the paucity of cells available for grafting from living or cadaver donors. This sourcing problem can be resolved, at least in theory, by generating tissue-specific cells from autologous or allogeneic stem cells. Nonetheless, there are formidable barriers to the use of stem cells in the clinic. This review focuses on identifying and surmounting these barriers.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
Clinical Applications of Epidermal Stem Cells
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Somatic cells are...

